Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-02

Clinical Trial Update: Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating L-Arginine supplementation as a treatment for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: RenJi Hospital | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN